Suven Pharmaceuticals Limited SUVENPHAR.NS
Trading inactive
SUVENPHAR.NS
Suven Pharmaceuticals Limited GLS.NS
Glenmark Life Sciences Limited GLS.BO
Glenmark Life Sciences Limited CAPPL.BO
Caplin Point Laboratories Limited NOVARTIND.NS
Novartis India Limited VIVIMEDLAB.NS
Vivimed Labs Limited LINCOPH.BO
Lincoln Pharmaceuticals Limited BAFNAPHARM.BO
Bafna Pharmaceuticals Limited INDSWFTLTD.BO
Ind-Swift Limited INDSWFTLTD.NS
Ind-Swift Limited
Suven Pharmaceuticals Limited GLS.NS
Glenmark Life Sciences Limited GLS.BO
Glenmark Life Sciences Limited CAPPL.BO
Caplin Point Laboratories Limited NOVARTIND.NS
Novartis India Limited VIVIMEDLAB.NS
Vivimed Labs Limited LINCOPH.BO
Lincoln Pharmaceuticals Limited BAFNAPHARM.BO
Bafna Pharmaceuticals Limited INDSWFTLTD.BO
Ind-Swift Limited INDSWFTLTD.NS
Ind-Swift Limited
Performance
| Periode | SUVENPHAR.NS | GLS.NS | GLS.BO | CAPPL.BO | NOVARTIND.NS | VIVIMEDLAB.NS | LINCOPH.BO | BAFNAPHARM.BO | INDSWFTLTD.BO | INDSWFTLTD.NS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -15.12 % | 11.30 % | 11.24 % | 18.56 % | -5.64 % | -38.51 % | 45.63 % | 14.51 % | 10.72 % | 9.29 % |
| YTD | -3.96 % | 6.65 % | 6.83 % | 6.74 % | 0.16 % | -56.77 % | -0.51 % | 8.02 % | -52.91 % | -52.60 % |
| 1Y | 44.03 % | 23.62 % | 24.20 % | 18.56 % | 2.38 % | -49.49 % | 98.00 % | 1.70 % | -34.85 % | -35.33 % |
| 3Y | 125.38 % | 108.45 % | 108.51 % | 18.56 % | 1.30 % | -76.48 % | 195.78 % | -13.82 % | 60.86 % | 55.27 % |
| 5Y | 553.53 % | 45.09 % | 45.12 % | 18.56 % | -1.30 % | -92.44 % | 243.46 % | 13.90 % | 380.12 % | 408.39 % |
| 10Y | 539.67 % | 45.09 % | 45.12 % | 18.56 % | -1.30 % | -82.98 % | 1 426.67 % | -53.82 % | 246.58 % | 242.61 % |
| From the beginning | 539.67 % | 45.09 % | 45.12 % | 18.56 % | -1.30 % | -88.68 % | 5 005.20 % | -73.37 % | 39.93 % | -62.20 % |